Metformin Prevents Renal Fibrosis in Mice with Unilateral Ureteral Obstruction and Inhibits Ang II-Induced ECM Production in Renal Fibroblasts
Renal fibrosis is the final common pathway of chronic kidney disease (CKD), and no effective medication is available clinically for managing its progression. Metformin was initially developed as an anti-diabetic drug and recently gained attention for its potential in the treatment of other diseases....
Main Authors: | Yang Shen, Naijun Miao, Jinlan Xu, Xinxin Gan, Dan Xu, Li Zhou, Hong Xue, Wei Zhang, Limin Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/17/2/146 |
Similar Items
-
Phenformin Attenuates Renal Injury in Unilateral Ureteral Obstructed Mice without Affecting Immune Cell Infiltration
by: Mikkel Ø. Nørgård, et al.
Published: (2020-03-01) -
Metformin and Renal Protection
by: Mahmoud Rafieian-Kopaei, et al.
Published: (2014-12-01) -
Metformin modulates immune cell infiltration into the kidney during unilateral ureteral obstruction in mice
by: Michael Christensen, et al.
Published: (2019-07-01) -
The Role of Apelin on the Alleviative Effect of Angiotensin Receptor Blocker in Unilateral Ureteral Obstruction-Induced Renal Fibrosis
by: Masashi Nishida, et al.
Published: (2012-03-01) -
Unilateral ureteric obstruction: Role of renin angiotensin system blockade on renal recovery: An experimental study
by: Anand Sinha, et al.
Published: (2012-01-01)